DrugPatentWatch Database Preview
FENOGLIDE Drug Profile
see a sample report or, see our see our flat-rate plans
When do Fenoglide patents expire, and when can generic versions of Fenoglide launch?
This drug has twenty-nine patent family members in eleven countries.
The generic ingredient in FENOGLIDE is fenofibrate. There are forty-two drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the fenofibrate profile page.
Summary for FENOGLIDE
| International Patents: | 29 |
| US Patents: | 4 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 4 |
| Bulk Api Vendors: | 96 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,366 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for FENOGLIDE |
| DailyMed Link: | FENOGLIDE at DailyMed |
Pharmacology for FENOGLIDE
| Ingredient-type | PPAR alpha |
| Drug Class | Peroxisome Proliferator Receptor alpha Agonist |
| Mechanism of Action | Peroxisome Proliferator-activated Receptor alpha Agonists |
Medical Subject Heading (MeSH) Categories for FENOGLIDE
Synonyms for FENOGLIDE
| 2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester |
| 2-[4-(4-CHLOROBENZOYL)PHENOXY]-2-METHYL-PROPANOIC ACID 1-METHYLETHYL ESTER |
| 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid,1-methylethylester |
| 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic acid 1-methyl-ethyl ester |
| 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic acid 1-methylethyl ester |
| 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic acid isopropyl ester |
| 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoicacidisopropylester |
| 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropionic Acid Isopropyl Ester |
| 2-[4-[(4-chlorophenyl)-oxomethyl]phenoxy]-2-methylpropanoic acid propan-2-yl ester |
| 2-1-methylethyl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate |
| 28073-EP2272825A2 |
| 28073-EP2272841A1 |
| 28073-EP2277565A2 |
| 28073-EP2277566A2 |
| 28073-EP2277567A1 |
| 28073-EP2277568A2 |
| 28073-EP2277569A2 |
| 28073-EP2277570A2 |
| 28073-EP2287163A1 |
| 28073-EP2287165A2 |
| 28073-EP2287166A2 |
| 28073-EP2292280A1 |
| 28073-EP2292620A2 |
| 28073-EP2295409A1 |
| 28073-EP2298742A1 |
| 28073-EP2298776A1 |
| 28073-EP2301923A1 |
| 28073-EP2301936A1 |
| 28073-EP2305678A1 |
| 28073-EP2314588A1 |
| 49562-28-9 |
| 562F289 |
| A827746 |
| AB00052196 |
| AB00052196_17 |
| AB00052196_18 |
| AB00052196-15 |
| AB00052196-16 |
| AB0012237 |
| AB03716 |
| AB2000298 |
| Abbott Brand of Procetofen |
| AbZ Brand of Procetofen |
| AC-4227 |
| AC1L1FPK |
| AJ-23609 |
| AK-88651 |
| AKOS005107777 |
| ALBB-028958 |
| Aliud Brand of Procetofen |
| AN-9654 |
| Ankebin |
| Antara |
| Antara (micronized) |
| Antara (TN) |
| Antara Micronized Procetofen |
| Anto Brand of Procetofen |
| ANW-41658 |
| API0003184 |
| API0025994 |
| API0026002 |
| API0026009 |
| Apo Feno Micro |
| Apo Fenofibrate |
| Apo-Feno-Micro |
| Apo-Fenofibrate |
| Apotex Brand of Procetofen |
| AX8021009 |
| AZU, Fenofibrat |
| Azupharma Brand of Procetofen |
| BC202978 |
| BDBM50085042 |
| betapharm Brand of Procetofen |
| BG0483 |
| BIDD:GT0574 |
| Bouchara Brand of Procetofen |
| BPBio1_000166 |
| BRD-K50388907-001-05-6 |
| BRD-K50388907-001-18-9 |
| BRN 2062462 |
| BSPBio_000150 |
| BSPBio_003162 |
| C-20905 |
| C07586 |
| C20H21ClO4 |
| CAS-49562-28-9 |
| CC-28385 |
| CCG-38996 |
| CCRIS 7282 |
| CHEBI:5001 |
| CHEMBL672 |
| CIP-Fenofibrate |
| clorofibrate |
| Controlip |
| CPD000058299 |
| CS-0892 |
| ct Arzneimittel Brand of Procetofen |
| ct-Arzneimittel Brand of Procetofen |
| CTK8B3039 |
| D00565 |
| D07XGR |
| DB01039 |
| Debat, Fenofibrate |
| DivK1c_000557 |
| DR001912 |
| DSSTox_CID_9874 |
| DSSTox_GSID_29874 |
| DSSTox_RID_78828 |
| DTXSID2029874 |
| durafenat |
| EBD45918 |
| EC 256-376-3 |
| EINECS 256-376-3 |
| Elasterate |
| Elasterin |
| EU-0100486 |
| F 6020 |
| F0674 |
| Fenobeta |
| Fenobrate |
| Fenocor-67 (TN) |
| Fenofanton |
| Fenofibrat AbZ |
| Fenofibrat AL |
| Fenofibrat AZU |
| Fenofibrat FPh |
| Fenofibrat Heumann |
| Fenofibrat Hexal |
| Fenofibrat ratiopharm |
| Fenofibrat Stada |
| fenofibrat von ct |
| Fenofibrat-ratiopharm |
| fenofibrate |
| Fenofibrate (JAN/INN) |
| FENOFIBRATE (MICRONIZED) |
| FENOFIBRATE (MICRONIZED) (fenofibrate |
| Fenofibrate (Tricor, Trilipix) |
| Fenofibrate [INN:BAN] |
| Fenofibrate [USAN:USP:INN:BAN] |
| Fenofibrate Debat |
| Fenofibrate IDD-P |
| Fenofibrate MSD |
| Fenofibrate, >=99%, powder |
| Fenofibrate, analytical reference material |
| Fenofibrate, European Pharmacopoeia (EP) Reference Standard |
| Fenofibrate, pharmaceutical secondary standard; traceable to USP and PhEur |
| Fenofibrate, United States Pharmacopeia (USP) Reference Standard |
| fenofibrate; |
| Fenofibrato |
| Fenofibrato [INN-Spanish] |
| Fenofibratum |
| Fenofibratum [INN-Latin] |
| FENOFIBRITE |
| Fenogal |
| Fenogal (TN) |
| Fenomax |
| Fenotard |
| Fibricor |
| Finofibrate |
| FNF |
| Fournier Brand of Procetofen |
| FT-0626400 |
| FT-0654669 |
| Fulcro |
| Gate Brand of Procetofen |
| Gen Fenofibrate |
| Gen-Fenofibrate |
| Genpharm Brand of Procetofen |
| GNR Pharma Brand of Procetofen |
| GNR-Pharma Brand of Procetofen |
| GP4850 |
| GRS-027 |
| GTPL7186 |
| Heumann Brand of Procetofen |
| Heumann, Fenofibrat |
| Hexal Brand of Procetofen |
| Hexal, Fenofibrat |
| HMS1568H12 |
| HMS1921B17 |
| HMS2090G20 |
| HMS2092B05 |
| HMS2095H12 |
| HMS2231B14 |
| HMS3259K03 |
| HMS3261B13 |
| HMS3369M13 |
| HMS3649D20 |
| HMS3655K12 |
| HMS501L19 |
| HSDB 7736 |
| HY-17356 |
| I06-0048 |
| IDI1_000557 |
| Isopropyl (4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl)propionate |
| Isopropyl (4''-(p-chlorobenzoyl)-2-phenoxy-2-methyl)propionate |
| Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoate |
| Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate |
| Isopropyl 2-(p-(p-chlorobenzoyl)phenoxy)-2-methylpropionate |
| isopropyl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoate |
| isopropyl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate |
| Isopropyl 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropionate |
| Isopropyl 2-[p-(p-chlorobenzoyl)phenoxy]-2-methylpropionate |
| J10318 |
| K-9221 |
| KBio1_000557 |
| KBio2_001730 |
| KBio2_004298 |
| KBio2_006866 |
| KBio3_002382 |
| KBioGR_000706 |
| KBioSS_001730 |
| Knoll Brand of Procetofen |
| KS-00000655 |
| LCP-Feno |
| LCP-FenoChol |
| LF 178 |
| LF-178 |
| LF178 |
| Lichtenstein Brand of Procetofen |
| Lipanthyl |
| Lipanthyl (TN) |
| Lipantil |
| Lipantil (TN) |
| Liparison |
| Lipidex |
| Lipidil |
| Lipidil (TN) |
| Lipidil Micro |
| Lipidil Supra |
| Lipidil Ter |
| Lipidil-Ter |
| Lipifen |
| Lipirex |
| Lipoclar |
| Lipofen |
| Lipofen (TN) |
| Lipofene |
| Liposit |
| Lipsin |
| Lofibra |
| Lofibra (TN) |
| Lopac-F-6020 |
| Lopac0_000486 |
| LP00486 |
| LS-121256 |
| Luxacor |
| MCULE-9460650238 |
| Merck dura Brand of Procetofen |
| METHYLETHYL 2-(4-[(4-CHLOROPHENYL)CARBONYL]PHENOXY)-2-METHYLPROPANOATE |
| methylethyl 2-{4-[(4-chlorophenyl)carbonyl]phenoxy}-2-methylpropanoate |
| MFCD00133314 |
| Micronized Procetofen, Antara |
| MLS000028515 |
| MLS001148191 |
| MLS002548878 |
| MolPort-002-887-051 |
| MS-2223 |
| MTW Brand of Procetofen |
| MTW Fenofibrat |
| MTW-Fenofibrat |
| NC00452 |
| NCGC00015437-01 |
| NCGC00015437-02 |
| NCGC00015437-03 |
| NCGC00015437-04 |
| NCGC00015437-05 |
| NCGC00015437-06 |
| NCGC00015437-07 |
| NCGC00015437-08 |
| NCGC00015437-09 |
| NCGC00015437-10 |
| NCGC00015437-11 |
| NCGC00015437-12 |
| NCGC00015437-13 |
| NCGC00015437-14 |
| NCGC00015437-16 |
| NCGC00015437-17 |
| NCGC00021475-03 |
| NCGC00021475-04 |
| NCGC00021475-05 |
| NCGC00021475-06 |
| NCGC00021475-07 |
| NCGC00021475-08 |
| NCGC00253945-01 |
| NCGC00261171-01 |
| NINDS_000557 |
| Nolipax |
| Novartis Brand of Procetofen |
| Novo Fenofibrate |
| Novo-Fenofibrate |
| Novopharm Brand of Procetofen |
| NSC 281319 |
| NSC-281319 |
| NSC-757822 |
| NSC281319 |
| NSC757822 |
| Nu Fenofibrate |
| Nu Pharm Brand of Procetofen |
| Nu-Fenofibrate |
| Nu-Pharm Brand of Procetofen |
| Opera_ID_328 |
| OR108780 |
| OR273579 |
| OR273580 |
| Pharmakon1600-01501010 |
| Pharmascience Brand of Procetofen |
| Pharmavit |
| Phenofibrate |
| PMS Fenofibrate Micro |
| PMS-Fenofibrate Micro |
| Prestwick_217 |
| Prestwick0_000275 |
| Prestwick1_000275 |
| Prestwick2_000275 |
| Prestwick3_000275 |
| Procetofen |
| Procetofen Reliant Brand |
| Procetofen, Antara Micronized |
| Procetofene |
| Procetoken |
| Proctofene |
| propan-2-yl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate |
| propan-2-yl 2-[4-(4-chlorophenyl)carbonylphenoxy]-2-methyl-propanoate |
| propan-2-yl 2-{4-[(4-chlorophenyl)carbonyl]phenoxy}-2-methylpropanoate |
| PROPAN-2-YL-2-(4-[(4-CHLOROPHENYL)CARBONYL]PHENOXY)-2-METHYLPROPANOATE |
| Propanoic acid, 2-(4-(4-chlorobenzoyl)phenoxy)-2-methyl-, 1-methylethyl ester |
| Propanoic acid, 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-, 1-methylethyl ester |
| Protolipan |
| PubChem17489 |
| Q Pharm Brand of Procetofen |
| Q-201111 |
| Q-Pharm Brand of Procetofen |
| ratiopharm Brand of Procetofen |
| Reliant Brand of Procetofen |
| s1794 |
| SAM002264613 |
| SBB037926 |
| SBI-0050470.P003 |
| SCHEMBL4670 |
| Schering Plough Brand of Procetofen |
| Schering-Plough Brand of Procetofen |
| Secalip |
| Sedufen |
| SMR000058299 |
| SPBio_001380 |
| SPBio_002369 |
| Spectrum_001250 |
| SPECTRUM1501010 |
| Spectrum2_001390 |
| Spectrum3_001431 |
| Spectrum4_000413 |
| Spectrum5_001479 |
| SR-01000000091 |
| SR-01000000091-16 |
| SR-01000000091-5 |
| ST085313 |
| Stada, Fenofibrat |
| Stadapharm Brand of Procetofen |
| Supralip |
| TC-130403 |
| TL8003296 |
| Tox21_110147 |
| Tox21_110147_1 |
| Tox21_300151 |
| Tox21_500486 |
| Tricor |
| TRICOR (MICRONIZED) |
| Tricor (TN) |
| Triglide |
| Triglide (TN) |
| U202363UOS |
| UNII-U202363UOS |
| United Drug Brand of Procetofen |
| YMTINGFKWWXKFG-UHFFFAOYSA-N |
| Z2768724415 |
| ZB014484 |
| ZINC584092 |
| ZX-AN079771 |
US Patents and Regulatory Information for FENOGLIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Santarus Inc | FENOGLIDE | fenofibrate | TABLET;ORAL | 022118-001 | Aug 10, 2007 | AB | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | ||
| Santarus Inc | FENOGLIDE | fenofibrate | TABLET;ORAL | 022118-002 | Aug 10, 2007 | AB | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | ||
| Santarus Inc | FENOGLIDE | fenofibrate | TABLET;ORAL | 022118-001 | Aug 10, 2007 | AB | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | ||
| Santarus Inc | FENOGLIDE | fenofibrate | TABLET;ORAL | 022118-002 | Aug 10, 2007 | AB | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | ||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
Paragraph IV (Patent) Challenges for FENOGLIDE
| Drugname | Dosage | Strength | RLD | Date |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 40 mg and 120 mg | ➤ Subscribe | ➤ Try a Free Trial |
Non-Orange Book US Patents for FENOGLIDE
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 7,772,273 | Stabilized atorvastatin | ➤ Try a Free Trial |
| Patent No. | Title | Estimated Patent Expiration |
see a sample report or, see our see our flat-rate plans
International Patents for FENOGLIDE
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Canada | 2582405 | ➤ Try a Free Trial |
| Russian Federation | 2006115596 | ➤ Try a Free Trial |
| Russian Federation | 2343905 | ➤ Try a Free Trial |
| Mexico | PA06003813 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
